Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (KA 4199/1-1, WO 1746/1-2)
Innovative Medicines Initiative Joint Undertaking (115737-2)
Text and Data Mining valid from 2019-06-05
Received: 4 June 2018
Accepted: 28 May 2019
First Online: 5 June 2019
Compliance with ethical standards
: This work was supported by the German Research Foundation [Grant No. WO 1746/1-2 to Martin Wolkewitz and Grant No. KA 4199/1-1 to Thomas Heister]. Klaus Kaier has received support from the Innovative Medicines Initiative Joint Undertaking under Grant Agreement No. 115737-2 (Combatting bacterial resistance in Europe—molecules against Gram negative infections [COMBACTE-MAGNET]). The funders had no role in data collection and analysis, decision to publish, or preparation of the manuscript. The authors declare no conflicts of interest.
: This research involved no intervention, and all patient records were anonymized prior to use, in accordance with German data protection law. For this type of study formal consent is not required.